Impact of Dexamethasone on the Pathogen Profile of Critically Ill COVID-19 Patients.

Cathrin KoddeFinja TimmenSven HohensteinAndreas BollmannMarzia BonsignoreRalf Kuhlen Irit NachtigallSelcuk Tasci

Published in: Viruses (2023)

Our results show that the decision to treat COVID-19 patients with dexamethasone should be a matter of careful consideration as it involves risks and bacterial shifts.

Keyphrases

sars cov
high dose
low dose
decision making
human health
candida albicans